Wilms Joris - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 26, 2024, Wilms Joris's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Officer (SVP & CHIEF OPERATING OFFICER), and currently has 30,600 shares of Common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other YMAB insiders.
Data Source: SEC.
Wilms Joris - Insider Non-Derivative Transactions of YMAB Common stock
Wilms Joris - Insider Non-Derivative Transactions at YMAB
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 27, 2024 | Sell -- (Common Stock) | 5000 | 14.69 | 30600 |
| Jan 19, 2024 | Acquisition -- (Common Stock) | 17800 | 0 | 35600 |
| Jan 18, 2023 | Acquisition -- (Common stock) | 17800 | 0 | 17800 |